lobbying_activities: 2600787
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2600787 | 6a80140a-417f-423f-a5cd-0469b2babcad | Q1 | ELI LILLY AND COMPANY | 13392 | ELI LILLY AND COMPANY | 2021 | first_quarter | CSP | Multi-lateral threats to IP and the biopharmaceutical industry; Drug importation; Prescription drug value and access | Commerce, Dept of (DOC),Executive Office of the President (EOP),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Justice, Dept of (DOJ),Office of Management & Budget (OMB),SENATE,State, Dept of (DOS),U.S. Trade Representative (USTR) | 1840000 | 0 | 0 | 2021-04-19T09:47:49.270000-04:00 |